Search research articles
Contact Us
Filters
Showing results (311-320 of 338) with videos related to
Page
of 34
Sort By:
Alzheimer'S Research & Therapy
|
June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
Miracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Brain Communications
|
March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases
Heidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
Eric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
Acta Neuropathologica
|
June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
Charles D Chen, Erin E Franklin, Yan Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease
Charles D Chen, Austin McCullough, Brian Gordon, et al.
Neurology
|
March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases
Erlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial
Austin McCullough, Charles D Chen, Brian A Gordon, et al.
The Journal of Prevention of Alzheimer'S Disease
|
February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
Eric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Cell Genomics
|
June 30, 2023
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias
Karri Kaivola, Ruth Chia, Jinhui Ding, et al.
JAMA Neurology
|
April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
Michael A Nalls, Raquel Duran, Grisel Lopez, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 338) with videos related to
Sort By:
Page
of 34
Alzheimer'S Research & Therapy
|
June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
Miracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Brain Communications
|
March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases
Heidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
Eric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
Acta Neuropathologica
|
June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
Charles D Chen, Erin E Franklin, Yan Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease
Charles D Chen, Austin McCullough, Brian Gordon, et al.
Neurology
|
March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases
Erlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial
Austin McCullough, Charles D Chen, Brian A Gordon, et al.
The Journal of Prevention of Alzheimer'S Disease
|
February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
Eric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Cell Genomics
|
June 30, 2023
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias
Karri Kaivola, Ruth Chia, Jinhui Ding, et al.
JAMA Neurology
|
April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
Michael A Nalls, Raquel Duran, Grisel Lopez, et al.
Page
of 34